In this Issue
Advances in Embolization Technology, Applications, and Clinical Study
Guest Chief Medical Editor’s Page
By Jafar Golzarian, MD
Jafar Golzarian, MD, encapsulates the current state of embolization agents and a glimpse of what’s to come.
Considerations for tool selection in different scenarios.
By Parag J. Patel, MD, and Quinton S. Kelly, MD
Intra-arterial treatment options based on current data.
By Siobhan Flanagan, MD; Donna D’Souza, MD; and Jafar Golzarian, MD
Tools and techniques to allow tailored endoleak resolution and ultimately decrease aneurysm rupture rates.
By John Moriarty, MD, and Mahmood K. Razavi, MD, FSIR, FSVM
A preview of this postmarket registry that aims to provide worldwide data on embolization.
By Marc Sapoval, MD, PhD, and Gert Andersen, BSE
The rationale behind this therapeutic option for obese patients.
By Michael Wolf, MD; Susie Park, MD; and Gary Siskin, MD, FSIR
FEATURED TECHNOLOGYSponsored by Penumbra, Inc.
Experts share clinical experiences demonstrating the unique qualities of this system.
With Jafar Golzarian, MD; Parag J. Patel, MD; and Robert Beasley, MD
Benefits, clinical applications, and case presentations of the AMPLATZER Vascular Plug 4.
By Ripal T. Gandhi, MD, FSVM, and David Quintana, MD
SYMPLICITY HTN-3: Perspectives on How These Data Will Shape Future Application and Study of Renal Denervation
Ajay J. Kirtane, MD; Krishna J. Rocha-Singh, MD; and Prof. Darrel Francis discuss key data from the trial and its potential effect on patient care and the evaluation of interventional therapies for treatment-resistant hypertension.
CODING & REIMBURSEMENT
Clinical scenarios that show how to use the revised codes for various procedures.
By Katharine L. Krol, MD, FSIR, FACR
A fictional account representing physicians’ common concerns and how to communicate with your industry contacts to ensure reported payments are properly perceived by the public.
By Steven J. Cagnetta, Esq, and Steven K. Ladd
INVENTION AND INTELLECTUAL PROPERTY
The second step in bringing your medical device to market is to understand whether you can protect your invention.
By Gerard von Hoffmann, JD, and Bryan Wahl, MD, JD
A preview of today's new products.
The interventional cardiologist shares his insights on below-the-knee interventions and the future of renal denervation and drug-coated balloon technologies.